These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9303359)

  • 1. Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients.
    Cariuk P; Lorite MJ; Todorov PT; Field WN; Wigmore SJ; Tisdale MJ
    Br J Cancer; 1997; 76(5):606-13. PubMed ID: 9303359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of muscle protein degradation by a tumour factor.
    Lorite MJ; Cariuk P; Tisdale MJ
    Br J Cancer; 1997; 76(8):1035-40. PubMed ID: 9376263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice.
    Beck SA; Tisdale MJ
    Cancer Res; 1989 Jul; 49(14):3800-4. PubMed ID: 2736521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of muscle protein degradation in cancer cachexia.
    Smith KL; Tisdale MJ
    Br J Cancer; 1993 Aug; 68(2):314-8. PubMed ID: 8347486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans.
    McDevitt TM; Todorov PT; Beck SA; Khan SH; Tisdale MJ
    Cancer Res; 1995 Apr; 55(7):1458-63. PubMed ID: 7882353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azaftig, a urinary proteoglycan from a cachectic cancer patient, causes profound weight loss in mice.
    Figueroa J; Vijayagopal P; Debata C; Prasad A; Prasad C
    Life Sci; 1999; 64(15):1339-47. PubMed ID: 10227590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor.
    Wigmore SJ; Todorov PT; Barber MD; Ross JA; Tisdale MJ; Fearon KC
    Br J Surg; 2000 Jan; 87(1):53-8. PubMed ID: 10606911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
    Mahony SM; Beck SA; Tisdale MJ
    Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a cancer cachectic factor.
    Todorov P; Cariuk P; McDevitt T; Coles B; Fearon K; Tisdale M
    Nature; 1996 Feb; 379(6567):739-42. PubMed ID: 8602222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine.
    Skipworth RJ; Stewart GD; Bhana M; Christie J; Sturgeon CM; Guttridge DC; Cronshaw AD; Fearon KC; Ross JA
    Int J Oncol; 2010 Apr; 36(4):973-82. PubMed ID: 20198343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
    Hirai K; Hussey HJ; Barber MD; Price SA; Tisdale MJ
    Cancer Res; 1998 Jun; 58(11):2359-65. PubMed ID: 9622075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catabolic factors in cancer cachexia.
    Tisdale MJ; McDevitt TM; Todorov PT; Cariuk P
    In Vivo; 1996; 10(2):131-6. PubMed ID: 8744791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice.
    van Norren K; Kegler D; Argilés JM; Luiking Y; Gorselink M; Laviano A; Arts K; Faber J; Jansen H; van der Beek EM; van Helvoort A
    Br J Cancer; 2009 Mar; 100(5):713-22. PubMed ID: 19259092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of muscle protein degradation and weight loss by a tumor product.
    Todorov PT; McDevitt TM; Cariuk P; Coles B; Deacon M; Tisdale MJ
    Cancer Res; 1996 Mar; 56(6):1256-61. PubMed ID: 8640810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice.
    Tanaka Y; Eda H; Tanaka T; Udagawa T; Ishikawa T; Horii I; Ishitsuka H; Kataoka T; Taguchi T
    Cancer Res; 1990 Apr; 50(8):2290-5. PubMed ID: 2317817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals.
    Bibby MC; Double JA; Ali SA; Fearon KC; Brennan RA; Tisdale MJ
    J Natl Cancer Inst; 1987 Mar; 78(3):539-46. PubMed ID: 3546909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model.
    Tisdale MJ; Dhesi JK
    Cancer Res; 1990 Aug; 50(16):5022-6. PubMed ID: 2379167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss in a murine cachexia model is not associated with the cytokines tumour necrosis factor-alpha or interleukin-6.
    Mulligan HD; Mahony SM; Ross JA; Tisdale MJ
    Cancer Lett; 1992 Aug; 65(3):239-43. PubMed ID: 1516039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid mobilising factors specifically associated with cancer cachexia.
    Beck SA; Tisdale MJ
    Br J Cancer; 1991 Jun; 63(6):846-50. PubMed ID: 2069843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sosiho‑tang ameliorates cachexia‑related symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss.
    Kim A; Im M; Ma JY
    Oncol Rep; 2016 Mar; 35(3):1841-50. PubMed ID: 26718030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.